Alternative Antibiotic for Augmentin-Associated Diarrhea
If a patient develops diarrhea on amoxicillin-clavulanate (Augmentin), switch to a macrolide (azithromycin or clarithromycin), a respiratory fluoroquinolone (levofloxacin or moxifloxacin), or cephalosporins (cefdinir, cefpodoxime, cefuroxime) depending on the infection being treated.
Understanding the Problem
Diarrhea is a well-documented adverse effect of amoxicillin-clavulanate, occurring when the clavulanate dose exceeds approximately 10 mg/kg per day 1. The FDA label explicitly warns that diarrhea is common with this antibiotic, and patients should contact their physician if it becomes severe or lasts more than 2-3 days 2. Clinical studies show protocol-defined diarrhea occurs in 11-13% of patients 2, with gastrointestinal side effects being particularly problematic with three-times-daily dosing 1.
Specific Alternatives Based on Infection Type
For Community-Acquired Pneumonia (Outpatient)
First-line alternatives:
- Respiratory fluoroquinolone (moxifloxacin, gemifloxacin, or levofloxacin 750 mg) - provides excellent coverage against S. pneumoniae including resistant strains, H. influenzae, and atypical pathogens 3
- Macrolide monotherapy (azithromycin, clarithromycin) - appropriate for previously healthy patients without risk factors for drug-resistant S. pneumoniae 3
- Doxycycline - effective alternative with lower gastrointestinal side effects 3
The choice depends on comorbidities: patients with chronic heart/lung disease, diabetes, or recent antibiotic use should receive fluoroquinolones rather than macrolides alone 3.
For Acute Bacterial Rhinosinusitis
Preferred alternatives:
- Cefpodoxime proxetil - third-generation cephalosporin with excellent activity against both S. pneumoniae and H. influenzae, often regarded as preferred treatment when high-dose amoxicillin fails or is intolerable 1
- Cefdinir - well-tolerated with comparable activity to cefuroxime against S. pneumoniae and good H. influenzae coverage 1
- Respiratory fluoroquinolones (levofloxacin, moxifloxacin) - broad coverage but reserve for more severe cases 4
Avoid: Cefaclor (poor H. influenzae activity) and cefixime (limited gram-positive coverage) 1.
For Infectious Diarrhea (If Treating Bacterial Cause)
This scenario is less common but important: if the patient was being treated for bacterial diarrhea and developed worsening diarrhea:
- Azithromycin (single 1-gm dose or 500 mg daily for 3 days) - first-line for dysentery and febrile diarrhea, generally well-tolerated with minimal GI side effects 5
- Fluoroquinolones - effective for non-dysenteric watery diarrhea but avoid in dysentery due to Campylobacter resistance 5
- Rifaximin - equivalent efficacy for watery non-invasive diarrhea 5
Critical Considerations
Distinguishing Antibiotic-Associated Diarrhea from C. difficile
Red flags requiring immediate evaluation:
- Watery and bloody stools
- Severe diarrhea with fever
- Symptoms persisting >2-3 days after stopping antibiotic
- Development of symptoms up to 2 months after antibiotic completion 2
If C. difficile infection is suspected, stop the offending antibiotic and treat with oral vancomycin or metronidazole 6, 7. Do not simply switch to another antibiotic for the original infection until C. difficile is ruled out.
Spectrum Coverage Considerations
When switching antibiotics, ensure the alternative covers the likely pathogens:
- S. pneumoniae (including resistant strains): Respiratory fluoroquinolones, high-dose cephalosporins (cefpodoxime, cefdinir), or macrolides
- H. influenzae: Cefpodoxime, cefdinir, fluoroquinolones, azithromycin
- Atypical pathogens (Mycoplasma, Chlamydophila): Macrolides, fluoroquinolones, doxycycline
Gastrointestinal Tolerability Profile
Lower GI side effect risk:
- Azithromycin: 3% nausea/vomiting rate (though higher in GI infections) 5
- Fluoroquinolones: Generally well-tolerated with mild, transient GI effects 5
- Cefdinir: Well-tolerated, particularly the suspension formulation 1
Higher GI side effect risk to avoid:
- Clindamycin: High rates of diarrhea and C. difficile-associated colitis 8
- Erythromycin: Poor GI tolerance 3
Practical Algorithm
- Assess diarrhea severity: Mild (manageable) vs. severe (>3 watery stools/day, bloody, febrile)
- If severe or concerning features: Stop antibiotic, evaluate for C. difficile, consider supportive care only
- If mild and infection requires continued treatment:
- For respiratory infections → Switch to respiratory fluoroquinolone OR macrolide (based on comorbidities)
- For sinusitis → Switch to cefpodoxime or cefdinir
- For bacterial diarrhea → Switch to azithromycin
- Monitor response: Clinical improvement should occur within 48-72 hours; if not, reassess diagnosis
Common Pitfalls
- Don't assume all diarrhea is benign: Always rule out C. difficile, especially if symptoms are severe or persistent
- Don't use cefaclor or cefixime as alternatives for respiratory infections—inadequate coverage 1
- Don't combine with probiotics as primary strategy: While probiotics may help prevent antibiotic-associated diarrhea 7, 9, switching to a better-tolerated antibiotic is more definitive
- Don't use fluoroquinolones indiscriminately: Reserve for appropriate indications to minimize resistance development 3, 8
The twice-daily formulation of amoxicillin-clavulanate has significantly lower GI side effects than three-times-daily dosing 1, but if diarrhea has already developed, switching antibiotic classes is the most practical solution.